{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T23:01:51Z","timestamp":1767135711936,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd007114","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,7,11]],"date-time":"2012-07-11T00:00:00Z","timestamp":1341964800000}}],"reference-count":53,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007114.pub2","type":"journal-article","created":{"date-parts":[[2012,7,6]],"date-time":"2012-07-06T15:32:32Z","timestamp":1341588752000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Orbital radiotherapy for adult thyroid eye disease"],"prefix":"10.1002","volume":"2012","author":[{"given":"Rathie","family":"Rajendram","sequence":"first","affiliation":[{"name":"Moorfields Eye Hospital NHS Foundation Trust; Adnexal Department; 162 City Road London UK EC1V 2PD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catey","family":"Bunce","sequence":"additional","affiliation":[{"name":"Moorfields Eye Hospital NHS Foundation Trust; Research and Development Department; City Road London UK EC1V 2PD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard WJ","family":"Lee","sequence":"additional","affiliation":[{"name":"University of Bristol; School of Clinical Sciences; Medical Sciences Building University Walk Bristol UK BS8 1TD"},{"name":"Moorfields Eye Hospital Foundation Trust and University College London Institute of Ophthalmology; NIHR Biomedical Research Centre for Ophthalmology; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana MS","family":"Morley","sequence":"additional","affiliation":[{"name":"St. Thomas's Hospital; Westminster Bridge Road London UK SE1 7EH"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,7,11]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD007114.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1210\/jcem-56-6-1139","article-title":"Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone","volume":"56","author":"Bartalena","year":"1983","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"9124","key":"10.1002\/14651858.CD007114.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(00)02165-6","article-title":"Radiotherapy for Graves' orbitopathy: randomised placebo-controlled study","volume":"355","author":"Mourits","year":"2000","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD007114.pub2-BIB0003|cit3","first-page":"322","article-title":"Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate-to-severe Graves' ophthalmopathy: a preliminary study","volume":"11","author":"Ng","year":"2005","journal-title":"Hong Kong Medical Journal"},{"issue":"8877","key":"10.1002\/14651858.CD007114.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0140-6736(93)92001-A","article-title":"Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy","volume":"342","author":"Prummel","year":"1993","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD007114.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1210\/jc.2003-030809","article-title":"A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild graves' ophthalmopathy","volume":"89","author":"Prummel","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD007114.pub2-BIB0006|cit6","first-page":"13","article-title":"High-dose intravenous immunoglobulin treatment in Graves' ophthalmopathy","volume":"126","author":"Antonelli","year":"1992","journal-title":"Acta Endocrinologica"},{"issue":"9","key":"10.1002\/14651858.CD007114.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0161-6420(01)00632-7","article-title":"A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy","volume":"108","author":"Gorman","year":"2001","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD007114.pub2-BIB0008|cit8","first-page":"1860","article-title":"Observation of curative effect of triamcinolone acetomide retrobular injection combined with orbital radiation on TAO","volume":"8","author":"Li","year":"2008","journal-title":"International Journal of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD007114.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1055\/s-0028-1128141","article-title":"Effect of combined intravenous glucocorticoids and orbital radiotherapy in restoring driving competency in patients with Graves' orbitopathy","volume":"41","author":"Sterker","year":"2009","journal-title":"Hormone and Metabolic Research"},{"issue":"20","key":"10.1002\/14651858.CD007114.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199311113292007","article-title":"Pathogenesis of Graves' ophthalmopathy","volume":"329","author":"Bahn","year":"1993","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD007114.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves' ophthalmopathy","volume":"362","author":"Bahn","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD007114.pub2-BIB0012|cit12","first-page":"168","article-title":"Management of Graves' ophthalmopathy: reality and perspectives","volume":"21","author":"Bartalena","year":"2000","journal-title":"Endocrine Reviews"},{"issue":"1","key":"10.1002\/14651858.CD007114.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1210\/jc.2003-031769","article-title":"Orbital radiotherapy for Graves' ophthalmopathy","volume":"89","author":"Bartalena","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"6","key":"10.1002\/14651858.CD007114.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/01.icu.0000144388.89867.03","article-title":"Orbital radiotherapy for thyroid-related orbitopathy","volume":"15","author":"Behbehani","year":"2004","journal-title":"Current Opinion in Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD007114.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ophtha.2007.10.028","article-title":"Orbital radiation for graves ophthalmopathy: a report by the American Academy of Ophthalmology","volume":"115","author":"Bradley","year":"2008","journal-title":"Ophthalmology"},{"issue":"7462","key":"10.1002\/14651858.CD007114.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/bmj.329.7462.385","article-title":"Recent developments in thyroid eye disease","volume":"329","author":"Cawood","year":"2004","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD007114.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1365-2265.2001.01349.x","article-title":"Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment","volume":"55","author":"Dickinson","year":"2001","journal-title":"Clinical Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD007114.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1210\/jcem-37-2-276","article-title":"Supervoltage orbital radiotherapy for Graves' ophthalmopathy","volume":"37","author":"Donaldson","year":"1973","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"3","key":"10.1002\/14651858.CD007114.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1530\/eje.1.02230","article-title":"Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers","volume":"155","author":"Wiersinga","year":"2006","journal-title":"European Journal of Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD007114.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1530\/eje.1.02201","article-title":"A questionnaire survey on the management of Graves' orbitopathy in Europe","volume":"155","author":"Perros","year":"2006","journal-title":"European Journal of Endocrinology"},{"issue":"9","key":"10.1002\/14651858.CD007114.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0161-6420(01)00729-1","article-title":"Radiation therapy for Graves' ophthalmopathy: trick or treat?","volume":"108","author":"Feldon","year":"2001","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD007114.pub2-BIB0022|cit22","first-page":"130","article-title":"How to identify randomized controlled trials in MEDLINE: ten years on","volume":"94","author":"Glanville","year":"2006","journal-title":"Journal of the Medical Library Association"},{"issue":"11","key":"10.1002\/14651858.CD007114.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0161-6420(02)01293-9","article-title":"The aftermath of orbital radiotherapy for graves' ophthalmopathy","volume":"109","author":"Gorman","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD007114.pub2-BIB0024|cit24","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"3","key":"10.1002\/14651858.CD007114.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/095530098141500","article-title":"Mechanisms of the anti-inflammatory activity of low-dose radiation therapy","volume":"74","author":"Hildebrandt","year":"1998","journal-title":"International Journal of Radiation Biology"},{"issue":"21","key":"10.1002\/14651858.CD007114.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/BF01711917","article-title":"Immunosuppressant therapy of thyroid eye disease","volume":"66","author":"Kahaly","year":"1988","journal-title":"Klinische Wochenschrift"},{"issue":"9","key":"10.1002\/14651858.CD007114.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1089\/thy.2007.0407","article-title":"Immune mechanisms in thyroid eye disease","volume":"18","author":"Lehmann","year":"2007","journal-title":"Thyroid"},{"issue":"8","key":"10.1002\/14651858.CD007114.pub2-BIB0028|cit28","first-page":"3562","article-title":"Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study","volume":"86","author":"Marcocci","year":"2001","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"8","key":"10.1002\/14651858.CD007114.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2003-030260","article-title":"Long-term safety of orbital radiotherapy for Graves' ophthalmopathy","volume":"88","author":"Marcocci","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"3","key":"10.1002\/14651858.CD007114.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0360-3016(01)01699-6","article-title":"Long-term results of irradiation for patients with progressive Graves' ophthalmopathy","volume":"51","author":"Marquez","year":"2001","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"1","key":"10.1002\/14651858.CD007114.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/bjo.86.1.102","article-title":"Does radiotherapy have a role in the management of thyroid orbitopathy?","volume":"86","author":"McNab","year":"2002","journal-title":"British Journal of Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD007114.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/bjo.73.8.639","article-title":"Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach","volume":"73","author":"Mourits","year":"1989","journal-title":"British Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD007114.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2265.1997.2331047.x","article-title":"Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy","volume":"47","author":"Mourits","year":"1997","journal-title":"Clinical Endocrinology"},{"issue":"1","key":"10.1002\/14651858.CD007114.pub2-BIB0034|cit34","first-page":"104","article-title":"Does radiotherapy have a role in the management of thyroid orbitopathy - View 2","volume":"86","author":"Mourits","year":"2002","journal-title":"British Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD007114.pub2-BIB0035|cit35","unstructured":"National Institute for Health and Clinical Excellence Retrobulbar irradiation for thyroid eye disease www.nice.org.uk\/ip257overview"},{"issue":"9104","key":"10.1002\/14651858.CD007114.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0140-6736(05)78494-4","article-title":"Transitory blindness after retrobulbar irradiation of Graves ophthalmopathy","volume":"351","author":"Nygaard","year":"1998","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD007114.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2265.1993.tb00516.x","article-title":"Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic","volume":"38","author":"Perros","year":"1993","journal-title":"Clinical Endocrinology"},{"issue":"20","key":"10.1002\/14651858.CD007114.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJM198911163212002","article-title":"Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy","volume":"321","author":"Prummel","year":"1989","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD007114.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1745-6215-9-6","article-title":"Protocol for the combined immunosuppression & radiotherapy in thyroid eye disease (CIRTED) trial: a multi-centre, double-masked, factorial randomised controlled trial","volume":"9","author":"Rajendram","year":"2008","journal-title":"Trials"},{"key":"10.1002\/14651858.CD007114.pub2-BIB0040|cit40","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011"},{"issue":"5","key":"10.1002\/14651858.CD007114.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/archopht.121.5.652","article-title":"Retinal microvascular abnormalities in patients treated with external radiation for graves ophthalmopathy","volume":"121","author":"Robertson","year":"2003","journal-title":"Archives of Ophthalmology"},{"key":"10.1002\/14651858.CD007114.pub2-BIB0042|cit42","first-page":"177","article-title":"Development and course of exophthalmos and ophthalmoplegia in Graves' disease with special reference to the effect of thyroidectomy","volume":"5","author":"Rundle","year":"1945","journal-title":"Clinical Science"},{"issue":"1","key":"10.1002\/14651858.CD007114.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0360-3016(01)01754-0","article-title":"A long-term follow-up study after retro-orbital irradiation for Graves' ophthalmopathy","volume":"52","author":"Schaefer","year":"2002","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1002\/14651858.CD007114.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/08916930310001603000","article-title":"The putative role of fibroblasts in the pathogenesis of Graves' disease: evidence for the involvement of the insulin-like growth factor-1 receptor in fibroblast activation","volume":"36","author":"Smith","year":"2003","journal-title":"Autoimmunity"},{"issue":"10","key":"10.1002\/14651858.CD007114.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1210\/jc.2004-0716","article-title":"Immunoglobulins from patients with Graves' disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor","volume":"89","author":"Smith","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"7","key":"10.1002\/14651858.CD007114.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1089\/thy.2010.1634","article-title":"Risk factors for development or deterioration of Graves' ophthalmopathy","volume":"20","author":"Stan","year":"2010","journal-title":"Thyroid"},{"issue":"8","key":"10.1002\/14651858.CD007114.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1210\/jc.2009-0376","article-title":"Treatment modalities for Graves' ophthalmopathy: systematic review and metaanalysis","volume":"94","author":"Stiebel-Kalish","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"3","key":"10.1002\/14651858.CD007114.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1365-2265.2001.01241.x","article-title":"Interpretation and validity of changes in scores on the Graves' ophthalmopathy quality of life questionnaire (GO-QOL) after different treatments","volume":"54","author":"Terwee","year":"2001","journal-title":"Clinical Endocrinology"},{"issue":"6","key":"10.1002\/14651858.CD007114.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1530\/eje.0.1460751","article-title":"Long-term effects of Graves' ophthalmopathy on health-related quality of life","volume":"146","author":"Terwee","year":"2002","journal-title":"European Journal of Endocrinology"},{"issue":"4","key":"10.1002\/14651858.CD007114.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3109\/01676831003668443","article-title":"The orbital fibroblast: a key player and target for therapy in Graves' ophthalmopathy","volume":"29","author":"Steensel","year":"2010","journal-title":"Orbit"},{"issue":"8","key":"10.1002\/14651858.CD007114.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.ophtha.2003.12.054","article-title":"Orbital irradiation for Graves' ophthalmopathy: is it safe? A long-term follow-up","volume":"111","author":"Wakelkamp","year":"2004","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD007114.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000109275","article-title":"The use of orbital radiotherapy for Graves' ophthalmopathy: quantitative review of the evidence","volume":"222","author":"Wei","year":"2008","journal-title":"Ophthalmologica"},{"issue":"1","key":"10.1002\/14651858.CD007114.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1210\/jcem-44-1-203","article-title":"Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association","volume":"44","author":"Werner","year":"1977","journal-title":"Journal of Clinical Endocrinology and Metabolism"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD007114.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T05:16:46Z","timestamp":1749619006000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007114.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Eyes and Vision Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,7,11]]},"references-count":53,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2012,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007114.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,11]]}}}